L. M. van Veenendaal

Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients

C. Verhoef, G. Valk, D. Grünhagen, 2018, Journal of surgical oncology.

ASO Author Reflections: Neuron-Specific Enolase as a Valuable Biomarker for Patients with Merkel Cell Carcinoma in the Era of Immunotherapy

A. V. van Akkooi, L. M. van Veenendaal, 2020, Annals of Surgical Oncology.

Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival

J. G. van den Berg, W. Verbeek, K. Kuhlmann, 2020, Journal of clinical medicine.

A Painful Finger as First Sign of a Malignancy

G. de Klerk, D. Velde, L. M. van Veenendaal, 2014, Geriatric orthopaedic surgery & rehabilitation.

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel

D. Sze, M. A. van den Bosch, R. van Hillegersberg, 2017, European Radiology.

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

S. Sleijfer, E. Cuppen, H. V. D. van de Werken, 2021, Nature Communications.

Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience.

C. Verhoef, D. Grünhagen, M. Tesselaar, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours

G. Meijer, P. Roepman, J. G. van den Berg, 2020, Histopathology.

Molecular prognostic factors in small-intestinal neuroendocrine tumours

J. G. van den Berg, G. Valk, K. Samsom, 2019, Endocrine connections.